The global bovine blood plasma derivatives market size accounted for USD 1.36 billion in 2025 and is forecasted to hit around USD 3.00 billion by 2034, representing a CAGR of 9.15% from 2025 to 2034. The North America market size was estimated at USD 500 million in 2024 and is expanding at a CAGR of 9.29% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Bovine Blood Plasma Derivatives Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Bovine Blood Plasma Derivatives Market Revenue and Volume, by Derivative Type
8.1.1 Fetal Bovine Serum (FBS)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Immunoglobulin
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Fibrinogen
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Serum Albumin (BSA)
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Newborn Calf Serum
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Thrombin
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Transferrin
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast
9.1. Bovine Blood Plasma Derivatives Market Revenue and Volume, by Application
9.1.1. Pharmaceuticals
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Cell Culture / Biotechnology
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Diagnostic Industry
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Research & Development
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Cosmetic Industry
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Food Industry
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Volume Forecast
10.1. Bovine Blood Plasma Derivatives Market Revenue and Volume, by End User
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Research Laboratories
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Food Processing Companies
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Veterinary Clinics
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Other Users
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Derivative Type
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End User
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Derivative Type
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by End User
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Derivative Type
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by End User
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Derivative Type
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End User
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Derivative Type
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by End User
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Derivative Type
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by End User
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Derivative Type
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by End User
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Derivative Type
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by End User
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Derivative Type
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by End User
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Derivative Type
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by End User
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Derivative Type
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by End User
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Derivative Type
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by End User
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Derivative Type
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by End User
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Derivative Type
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by End User
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Derivative Type
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by End User
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Derivative Type
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by End User
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Derivative Type
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by End User
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Derivative Type
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by End User
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Derivative Type
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by End User
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Derivative Type
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by End User
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Derivative Type
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by End User
12.1. Thermo Fisher Scientific
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Merck KGaA (SigmaAldrich)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. GE Healthcare / Cytiva
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. LAMPIRE Biological Laboratories
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Proliant Biologicals
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Tissue Culture Biologicals
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bovogen Biologicals
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Rocky Mountain Biologicals
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. SeraCare (MP Biomedical)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Kraeber & Co GmbH
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description